Analysis of metabolome changes in the bile acid pool in feces and plasma of antibiotic-treated rats.


Journal

Toxicology and applied pharmacology
ISSN: 1096-0333
Titre abrégé: Toxicol Appl Pharmacol
Pays: United States
ID NLM: 0416575

Informations de publication

Date de publication:
15 01 2019
Historique:
received: 13 09 2018
revised: 12 11 2018
accepted: 27 11 2018
pubmed: 7 12 2018
medline: 19 7 2019
entrez: 4 12 2018
Statut: ppublish

Résumé

The bile acid-liver-gut microbiota axis plays an important role in the host's health. The gut microbiota has an impact on the bile acid pool, but also the bile acids themselves can influence the gut microbiota composition. In this study, six antibiotics from five different classes (i.e. lincosamides, glycopeptides, macrolides, fluoroquinolones, aminoglycosides) were used to modulate microbial communities of Wistar rats to elucidate changes in the bile acid metabolism and to identify key metabolites in the bile acid pool related to gut microbial changes. 20 primary and secondary bile acids were analyzed in plasma and feces of control and treated animals. Antibiotics treatment induced significant changes in primary and secondary bile acids in both matrices. Taurine-conjugated primary bile acids significantly increased in plasma and feces. Contrary, cholic acid and most of the analyzed secondary bile acids significantly decreased in plasma, and cholic acid accumulated in the feces after treatment with all antibiotics but roxithromycin. Despite the different activity spectra of the antibiotics applied against gut microbes, the overall effect on the bile acid pool tended to be similar in both matrices except for streptomycin. These results show that changes in the gut microbial community affect the bile acid pool in plasma and feces and that changes in the bile acid profile can be indicative of alterations of the gut microbiome. Due to the important role of bile acids for the host, changes in the bile acid pool can have severe consequences for the host.

Identifiants

pubmed: 30502395
pii: S0041-008X(18)30515-5
doi: 10.1016/j.taap.2018.11.012
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bile Acids and Salts 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

79-87

Informations de copyright

Copyright © 2018. Published by Elsevier Inc.

Auteurs

C Behr (C)

BASF, SE, 67056 Ludwigshafen, Germany.

M Slopianka (M)

metanomics GmbH, 10589 Berlin, Germany.

V Haake (V)

metanomics GmbH, 10589 Berlin, Germany.

V Strauss (V)

BASF, SE, 67056 Ludwigshafen, Germany.

S Sperber (S)

BASF, SE, 67056 Ludwigshafen, Germany.

H Kamp (H)

BASF, SE, 67056 Ludwigshafen, Germany.

T Walk (T)

metanomics GmbH, 10589 Berlin, Germany.

K Beekmann (K)

Division of Toxicology, Wageningen University, 6700, EA, Wageningen, the Netherlands.

I M C M Rietjens (IMCM)

Division of Toxicology, Wageningen University, 6700, EA, Wageningen, the Netherlands.

B van Ravenzwaay (B)

BASF, SE, 67056 Ludwigshafen, Germany. Electronic address: bennard.ravenzwaay@basf.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH